Doxorubin 50 Injection

Description of Doxorubin 50 (Doxorubicin 50 mg) injection

Doxorubin injection 50 mg of doxorubicin which is a widely used anthracycline antibiotic that is widely used as an anticancer agent. Doxorubicin, originally discovered in the genus, Streptomyces, demonstrates effects of intense cytotoxicity in a wide range of malignancies. Its action is that it blocks DNA events in fast-growing cancer cells, and leads to the blockage of tumour growth and the apoptosis. Due to its broad spectrum action, the agent is often used in combination chemotherapy programmes.

Indications of Doxorubin 50 (Doxorubicin 50 mg) injection

Doxorubicin is used in the treatment of multiple types of cancers, including Breast cancer,  Leukemia, Sarcomas, Ovarian cancer, and Lung cancer. This is the kind of medication that is normally used in combination regimens to increase its therapeutic efficacy.

Mechanism of Action of Doxorubin 50 (Doxorubicin 50 mg) injection

Doxorubicin acts by having a variety of mechanisms. The drug binds between the base pairs of the DNA and interferes with the structure of DNA, affecting the replication and the transcription of the DNA. At the same time, it suppresses topoisomerase II enzyme that plays a crucial role in the repair and replication of DNA. Besides, doxorubicin produces reactive oxygen species, which induces oxidative damage on cellular components and thus further contributes to the cancer cell death. These joint actions have a suppressive effect on tumour growth and have a stimulating effect on apoptosis.

How to Consume Doxorubin 50 (Doxorubicin 50 mg) injection

Doxorubicin must be administered through intravenous infusion under severe medical care conditions in a hospital or an oncology environment. The protocol, tumour type and patient condition are modified to determine dosage, frequency and treatment cycle. The agent is normally administered in a cyclical way as a combination therapy. Infusion should be carefully followed to avoid extravasation that may cause serious tissue damage.

Side Effects of Doxorubin 50 (Doxorubicin 50 mg) injection

1. Common side effects

• Nausea and vomiting
• Hair loss (alopecia)
• Fatigue
• Mouth ulcers
• Loss of appetite

2. Serious side effects

• Severe bone marrow suppression
• Cardiotoxicity (heart damage)
• Severe infections
• Anemia and thrombocytopenia

3. Rare side effects

• Secondary malignancies
• Severe allergic reactions
• Liver toxicity

Safety Advice for Doxorubin 50 (Doxorubicin 50 mg) injection

Low doses of Doxorubicin should be accompanied with frequent monitoring of the patient such as blood counts and cardiac functions.

Breastfeeding: Contraindicated in treatment because of the harmful effect in the infant.

Pregnancy: Contraindicated as it may cause fetal toxicity.

Alcohol: This should be kept to a minimum in order to minimise further stress on liver functioning.

Liver: Dose adjustment may be required in hepatic impairment.

Lungs: Watch out to breathing complications in combination with other medications.

Kidney: Renal functioning should be observed in treatment.

Driving: Fatigue may occur; avoid driving if symptomatic.

Interaction of Doxorubin 50 (Doxorubicin 50 mg) injection

• Drug–Drug Interaction

Cyclophosphamide × Doxorubicin

May enhance the risk cardiotoxicity/bone marrow suppression.  .

Paclitaxel × Doxorubicin

May increase toxicity particularly cardiac and haematological effects.  .

Trastuzumab × Doxorubicin

Vastly raises the chances of heart dysfunction and heart failure.

Verapamil × Doxorubicin
May raise plasma concentration of Doxorubicin and raise toxicity.

Warfarin × Doxorubicin
May causes bleeding risks because it suppresses the bone marrow.

• Drug–Food Interaction

Doxorubicin is given through the intravenous route; hence, food has no direct impact on its absorption. Nonetheless, a healthy diet can be used to control the side effects and enhance recovery.

• Drug–Disease Interaction of Doxorubin 50 (Doxorubicin 50 mg) injection

Cardiac Disease

Doxorubicin is also famous in causing cardiotoxicity particularly when they are used in a cumulative dose. Careful cardiac monitoring of the patients who have pre-existing heart disease is necessary.

Bone Marrow Suppression

This drug is able to suppress the production of blood cells by a large extent. Patients who already have bone marrow disorders are prone to excessive complications.

Liver Disease

As Doxorubicin is hepatoxic, its metabolism increases in the liver releasing higher toxicity, thus subjecting the patient to hepatic impairment.

Infections      

Immunosuppression may have aggravated the symptoms of patients with active infections.

Contraindication of Doxorubin 50 (Doxorubicin 50 mg) injection

Doxorubicin should not be used in the patients with severe heart disease, severe bone marrow suppression, hypersensitivity to anthracyclines and in pregnant individuals.

Dosage of Doxorubin 50 (Doxorubicin 50 mg) injection

Calculation of the dosage is done according to the body surface area and treatment protocol. It is medically administered in cycles.

Storage of Doxorubin 50 (Doxorubicin 50 mg) injection

Storage of the drug is to be done in the recommended conditions and to avoid light. It should be stored away where children cannot reach them.

Missed Dose of Doxorubin 50 (Doxorubicin 50 mg) injection

As the administration is done in a clinical environment, there are few missed doses. The treating physician deals with any delay.

Other General Information of Doxorubin 50 (Doxorubicin 50 mg) injection

Patients are supposed to visit regularly during follow-ups and report any symptoms like; chest pain, fatigue or infection early enough. Good nutrition and hydration can be used to help minimise treatment related discomfort.

FAQs of Doxorubin 50 (Doxorubicin 50 mg) injection

1. What is the correlation between Doxorubicin and heart damage?

The drug produces free radicals, which may destroy the cardiac muscle cells, particularly during chronic usage or excessive cumulative dose.

2. What is the reason behind hair loss during treatment?

Doxorubicin has an impact on fast growing cells, such as hair follicles, and causes temporary hair loss.

3. What is the rationale of the blood tests during treatment?

The medication inhibits bone marrow, and thus, blood counts should be observed to avoid complications.

4. Is Doxorubicin any good as combination therapy?

Yes, together with other anticancer drugs, it is usually used to enhance treatment.

5. Why do we want to be careful with the administration?

Outside veinal leakage of Doxorubicin may result in serious tissue injury, and therefore, it should be used cautiously.

Fact Box of Doxorubin 50 (Doxorubicin 50 mg) injection

References

• FDA Prescribing Information – Doxorubicin
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050467s060lbl.pdf
• National Cancer Institute – Doxorubicin
  https://www.cancer.gov/about-cancer/treatment/drugs/doxorubicin
• DrugBank – Doxorubicin
  https://go.drugbank.com/drugs/DB00997
• European Medicines Agency – Doxorubicin
  https://www.ema.europa.eu